Emergency Department Initiation of Pharmacotherapy for Alcohol Use Disorder: A Retrospective Cohort Study
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Bouza C, Angeles M, Magro A, Munoz A, Amate J
. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction. 2004; 99(7):811-28.
DOI: 10.1111/j.1360-0443.2004.00763.x.
View
2.
Murphy 4th C, Coralic Z, Wang R, Montoy J, Ramirez B, Raven M
. Extended-Release Naltrexone and Case Management for Treatment of Alcohol Use Disorder in the Emergency Department. Ann Emerg Med. 2022; 81(4):440-449.
DOI: 10.1016/j.annemergmed.2022.08.453.
View
3.
Guyatt G, Oxman A, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P
. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-6.
PMC: 2335261.
DOI: 10.1136/bmj.39489.470347.AD.
View
4.
Punia K, Scott W, Manuja K, Sabbineni M, Campbell K, Balodis I
. SAEM GRACE: Anti-craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence. Acad Emerg Med. 2023; 31(5):504-514.
DOI: 10.1111/acem.14806.
View
5.
Anderson E, Chamberlin M, Zuluaga M, Ullal M, Hawk K, McCormack R
. Implementation of Oral and Extended-Release Naltrexone for the Treatment of Emergency Department Patients With Moderate to Severe Alcohol Use Disorder: Feasibility and Initial Outcomes. Ann Emerg Med. 2021; 78(6):752-758.
DOI: 10.1016/j.annemergmed.2021.05.013.
View